29 Aug, 2023 09:50 AM
Treatment of the third clinical trial participant, required to complete the final dose escalation cohort in the CHM 1101 Phase 1A clinical trial, has been completed at City of&n...read more
15 Aug, 2023 08:35 AM
Sydney, Australia, 15 August 2023: Chimeric Therapeutics (ASX:CHM, “Chimeric” or the “Company”), an Australian leader in cell therapy, is pleased to announce positive in vitr...read more
31 Jul, 2023 02:41 PM
Chimeric Therapeutics (ASX:CHM, “Chimeric” or the “Company”), an Australian leader in cell therapy, is pleased to provide a summary of its activities for the quarter ended 30...read more
31 Jul, 2023 09:01 AM
Careteq Limited (ASX: CTQ, “Careteq” or the “Company”), a leading cloud-based assistive living technology business, is pleased to provide the following quarterly update and c...read more
27 Jul, 2023 09:32 AM
Careteq Limited (ASX: CTQ) (Careteq or the Company), an emerging leader in assisted living technology, is pleased to announce that it has closed the institutional component (Institutional Entitlemen...read more
26 Jul, 2023 09:33 AM
Careteq Limited (ASX: CTQ) (Careteq or the Company), an emerging leader in assisted living technology, is pleased to announce a capital raising of approximately $2.47 million (before costs) via&n...read more